The mission of “European Biopharmaceutical Enterprises” (EBE) is to: Represent biopharmaceutical companies of all sizes operating in Europe in the formulation of policies at global and European levels. Focus on enhancing emerging healthcare technologies and promoting science innovation in Europe via expertise in: • Innovation eco-system and funding models • Emerging biotech & science - regulatory advancement and advocacy Contribute industry expertise to the development of new regulatory frameworks, guidelines and standards of relevance to biopharmaceuticals. Promote the exchange of good practices to foster the development of safe, efficacious and high-quality medicines. Increase awareness of the sector, its products and the tangible benefits that biopharmaceuticals bring to patients and society worldwide. Support the business development of member companies, especially SMEs, through advice, networking, training and educational opportunities. Facilitate in (...)